136 related articles for article (PubMed ID: 1587290)
1. Leukemia following cisplatin-based chemotherapy for ovarian carcinoma at Roswell Park.
Sprance HE; Hempling RE; Piver MS
Eur J Gynaecol Oncol; 1992; 13(2):131-7. PubMed ID: 1587290
[TBL] [Abstract][Full Text] [Related]
2. Secondary acute nonlymphocytic leukemia following successful chemotherapy combining cisplatin, doxorubicin, and cyclophosphamide for stage IV epithelial ovarian cancer.
Yokoyama Y; Futagami M; Fukushi Y; Sakamoto T; Higuchi T; Fujii S; Sato S; Takami H; Saito Y
Arch Gynecol Obstet; 2000 Apr; 263(4):206-7. PubMed ID: 10834334
[TBL] [Abstract][Full Text] [Related]
3. Secondary myelodysplasia and acute leukemia following carboplatin-containing combination chemotherapy for ovarian cancer.
Colon-Otero G; Malkasian GD; Edmonson JH
J Natl Cancer Inst; 1993 Nov; 85(22):1858-60. PubMed ID: 8230267
[No Abstract] [Full Text] [Related]
4. Surgically documented response to intraperitoneal cisplatin, cytarabine, and bleomycin after intravenous cisplatin-based chemotherapy in advanced ovarian adenocarcinoma.
Piver MS; Lele SB; Marchetti DL; Baker TR; Emrich LJ; Hartman AB
J Clin Oncol; 1988 Nov; 6(11):1679-84. PubMed ID: 3183700
[TBL] [Abstract][Full Text] [Related]
5. Chronic myeloid leukemia following cyclophosphamide-containing chemotherapy in a breast cancer patient.
Porta C; Casagranda I; Semino G; Moroni M; Ratto C
Haematologica; 1993; 78(1):56-7. PubMed ID: 8387943
[No Abstract] [Full Text] [Related]
6. Secondary acute non-lymphoblastic leukemia in two children following treatment with a cis-diamminedichloroplatinum-II-based regimen for osteosarcoma.
Jeha S; Jaffe N; Robertson R
Med Pediatr Oncol; 1992; 20(1):71-4. PubMed ID: 1727215
[TBL] [Abstract][Full Text] [Related]
7. Treatment-related acute myelomonocytic leukemia with t(11;19) in a child following chemotherapy for hepatoblastoma.
Koga Y; Matsuzaki A; Suminoe A; Washitoh N; Hara T; Hara T; Tajiri T; Taguchi T
Pediatr Blood Cancer; 2008 Apr; 50(4):943-4. PubMed ID: 17973320
[No Abstract] [Full Text] [Related]
8. Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
Kröger N; Damon L; Zander AR; Wandt H; Derigs G; Ferrante P; Demirer T; Rosti G; ; ;
Bone Marrow Transplant; 2003 Dec; 32(12):1153-7. PubMed ID: 14647269
[TBL] [Abstract][Full Text] [Related]
9. Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low-dose etoposide on Intergroup Rhabdomyosarcoma Study III: an interim report.
Heyn R; Khan F; Ensign LG; Donaldson SS; Ruymann F; Smith MA; Vietti T; Maurer HM
Med Pediatr Oncol; 1994; 23(2):99-106. PubMed ID: 8202048
[TBL] [Abstract][Full Text] [Related]
10. Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer.
Pedersen-Bjergaard J; Sigsgaard TC; Nielsen D; Gjedde SB; Philip P; Hansen M; Larsen SO; Rørth M; Mouridsen H; Dombernowsky P
J Clin Oncol; 1992 Sep; 10(9):1444-51. PubMed ID: 1517787
[TBL] [Abstract][Full Text] [Related]
11. [Therapy-related myeloid leukemia following platinum-based chemotherapy for ovarian cancer].
Shimura K; Shimazaki C; Okano A; Hatsuse M; Okamoto A; Takahashi R; Hirai H; Sumikuma T; Ashihara E; Inaba T; Fujita N; Yasuda J; Nakagawa M
Rinsho Ketsueki; 2001 Feb; 42(2):99-103. PubMed ID: 11280924
[TBL] [Abstract][Full Text] [Related]
12. Acute leukemia following cisplatin-based chemotherapy in a patient with ovarian cancer.
Reed E; Evans MK
J Natl Cancer Inst; 1990 Mar; 82(5):431-2. PubMed ID: 2304092
[No Abstract] [Full Text] [Related]
13. Development of leukemia after doxorubicin and cisplatin treatment for ovarian cancer.
Chambers SK; Chopyk RL; Chambers JT; Schwartz PE; Duffy TP
Cancer; 1989 Dec; 64(12):2459-61. PubMed ID: 2819655
[TBL] [Abstract][Full Text] [Related]
14. Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC).
Levenback C; Burke TW; Silva E; Morris M; Gershenson DM; Kavanagh JJ; Wharton JT
Gynecol Oncol; 1992 Sep; 46(3):317-21. PubMed ID: 1526508
[TBL] [Abstract][Full Text] [Related]
15. Secondary acute myeloid leukemia following treatment with VP16-containing regimens for non-Hodgkin's lymphoma.
Orlandi E; Lazzarino M; Bernasconi P; Astori C; Bernasconi C
Haematologica; 1998 Aug; 83(8):758-9. PubMed ID: 9793267
[TBL] [Abstract][Full Text] [Related]
16. Acute leukemia in advanced ovarian carcinoma after treatment with alkylating agents.
Sotrel G; Jafari K; Lash AF; Stepto RC
Obstet Gynecol; 1976 Jan; 47(1):67S-71S. PubMed ID: 1061006
[TBL] [Abstract][Full Text] [Related]
17. [The second look at tumors of the ovary. Our experience].
Sanlorenzo M; Vigezzi P; Caldarola F; Allone T
Minerva Chir; 1988 Sep; 43(18):1477-9. PubMed ID: 2465506
[No Abstract] [Full Text] [Related]
18. Topoisomerase II inhibitor induced leukemia in a patient with AIDS.
Nabil S; Thomas F; Douglas R; Michael B
AIDS; 2001 Feb; 15(3):421-3. PubMed ID: 11273227
[No Abstract] [Full Text] [Related]
19. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Wadler S; Yeap B; Vogl S; Carbone P
Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
[TBL] [Abstract][Full Text] [Related]
20. Cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin (CHAD) as second-line chemotherapy for ovarian adenocarcinoma.
Piver MS; Lele S; Barlow JJ
Cancer Treat Rep; 1981; 65(1-2):149-51. PubMed ID: 6784921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
